Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo

Anesthesia and Analgesia

Volumn 105, Issue 3, 2007, Pages 562-569

  Pagel, Paul S ^a,b   Krolikowski, John G ^a   Shim, Yon Hee ^a   Venkatapuram, Suneetha ^a   Kersten, Judy R ^a   Weihrauch, Dorothee ^a   Warltier, David C ^a,b   Pratt Jr , Phillip F ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Medical College of Wisconsin and Marquette University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARGON; ATRACTYLOSIDE; DIMETHYL SULFOXIDE; HELIUM; INERT GAS; MITOGEN ACTIVATED PROTEIN KINASE; NEON; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; RAPAMYCIN; S6 KINASE; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM; WORTMANNIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART PROTECTION; HEMODYNAMICS; IN VIVO STUDY; ISCHEMIA; ISCHEMIC PRECONDITIONING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRIAL PERMEABILITY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION; SIGNAL TRANSDUCTION; STAINING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ARGON; ATRACTYLOSIDE; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HEART VENTRICLES; HELIUM; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEON; NOBLE GASES; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RABBITS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 34548134885     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000278083.31991.36     Document Type: Article

References (36)

1. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000;91:1327-32
2. Weber NC, Toma O, Wolter JI, Obal D, Mullenheim J, Preckel B, Schlack W. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-ε and p38 MAPK. Br J Pharmacol 2005;144:123-32
3. ATP channels and PDK-1. Eur J Pharmacol 2006;539:1-9
4. Weber NC, Toma O, Awan S, Frassdorf J, Preckel B, Schlack W. Effects of nitrous oxide on the rat heart in vivo. Another inhalational anesthetic that preconditions the heart? Anesthesiology 2005;103:1174-82
5. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B. Mechanisms of xenon- and isoflurane-induced preconditioning. A potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 2005;146:445-55
6. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004;100:707-21
7. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006;105:187-97
8. Koblin DD, Fang Z, Eger EI II, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 1998;87:419-24
9. Trudell JR, Koblin DD, Eger EI II. A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth Analg 1998;87:411-18
10. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-60
11. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts. Circ Res 2004;94:960-6
12. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Waritier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005;102:102-9
13. Krolikowski JG, Weihrauch D, Bienengraeber M, Warltier DC, Kersten JR, Pagel PS. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth 2006;53:174-82
14. Weihrauch D, Krolikowski JG, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS. Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 2005;101:942-9
15. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 2002;55:534-43
16. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M. Specific inhibition of mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367-74
17. 2+-induced mitochondrial permeability transition. Cardiovasc Res 2004;61:115-22
18. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Olize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005;111:194-7
19. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischemia but open upon reperfusion. Biochem J 1995;307:93-8
20. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001;276:2571-5
21. Bernardi P, Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 1996;28:131-6
22. Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci 1999;874:412-26
23. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-49
24. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-14
25. Piriou V, Chiari P, Gateau-Roesch O, Argaud L, Muntean D, Salles D, Loufouat J, Gueugniaud PY, Lehot JJ, Ovize M. Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 2004;100:581-8
26. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: role of mitochondrial KATP channels. Anesth Analg 2005;101:1590-6
27. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 2002;97:1485-90
28. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001;296:642-9
29. Warltier DC, Zyvoloski MG, Gross GJ, Hardman HF, Brooks HL. Determination of experimental myocardial infarct size. J Pharmacol Methods 1981;6:199-210
30. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B. Xenon preconditioning differently regulates p44/42 MAPK (ERK1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br J Anaesth 2006;97:298-306
31. Brenner C, Cadiou H, Vieira HLA, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC, Kroemer G. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000;19:329-36
32. Kopustinskiene DM, Toleikis A, Saris NEL. Adenine nucleotide translocase mediates the KATP-channel-openers-induced proton and potassium flux to the mitochondrial matrix. J Bioenerg Biomembr 2003;35:141-8
33. Balakirev MY, Khramtsov VV, Zimmer G. Modulation of the mitochondrial permeability transition by nitric oxide. Eur J Biochem 1997;246:710-18
34. Xu Y, Tang P. Amphiphilic sites for general anesthesia action? Evidence from 129Xe-{1H} intermolecular nuclear Overhauser effects. Biochim Biophys Acta 1997;1323:154-62
35. Merzbacher E. Quantum mechanics. 2nd ed. New York: John Wiley and Sons, 1970
36. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46